Gianni Bonadonna

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Gianni Luca; Norton Larry; Wolmark Norman; Suter Thomas M; Bonadonna Gianni; Hortobagyi Gabriel N
Role of anthracyclines in the treatment of early breast cancer.
Gianni Luca; Baselga José; Eiermann Wolfgang; Porta Vincente Guillem; Semiglazov Vladimir; Lluch Ana; Zambetti Milvia; Sabadell Dolores; Raab Günther; Cussac Antonio Llombart; Bozhok Alla; Martinez-Agulló Angel; Greco Marco; Byakhov Mikhail; Lopez Juan Josè Lopez; Mansutti Mauro; Valagussa Pinuccia; Bonadonna Gianni
Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer.
Demicheli Romano; Hrushesky William J M; Retsky Michael W; Bonadonna Gianni; Valagussa Pinuccia
Comment to "Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and intact primary tumor" by G V Babiera, R Rao, L Feng, F Meric-Bernstam, H M Kuerer, S E Singletary, K K Hunt, M I Ross, K M Gwyn, B W Feig, F C Ames, G N Horthobagyi. Ann Surg Oncol 2006;13:776-782.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Gianni Bonadonna (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Gianni Luca; Norton Larry; Wolmark Norman; Suter Thomas M; Bonadonna Gianni; Hortobagyi Gabriel N
Role of anthracyclines in the treatment of early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(28):4798-808.
2009: Gianni Luca; Baselga José; Eiermann Wolfgang; Porta Vincente Guillem; Semiglazov Vladimir; Lluch Ana; Zambetti Milvia; Sabadell Dolores; Raab Günther; Cussac Antonio Llombart; Bozhok Alla; Martinez-Agulló Angel; Greco Marco; Byakhov Mikhail; Lopez Juan Josè Lopez; Mansutti Mauro; Valagussa Pinuccia; Bonadonna Gianni
Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(15):2474-81.
2007: Demicheli Romano; Hrushesky William J M; Retsky Michael W; Bonadonna Gianni; Valagussa Pinuccia
Comment to "Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and intact primary tumor" by G V Babiera, R Rao, L Feng, F Meric-Bernstam, H M Kuerer, S E Singletary, K K Hunt, M I Ross, K M Gwyn, B W Feig, F C Ames, G N Horthobagyi. Ann Surg Oncol 2006;13:776-782.
Annals of surgical oncology 2007;14(4):1519-20.
2006: Demicheli Romano; Bonadonna Gianni; Greco Marco; Hrushesky William J M; Moliterni Angela; Retsky Michael W; Valagussa Pinuccia; Zambetti Milvia
Comment to Anderson WF, Jatoi I, Devesa SS: distinct breast cancer incidence and prognostic patterns in the NCI'S SEER program: suggesting a possible link between etiology and outcome. Breast Cancer Res Treat 90:127-137, 2005.
Breast cancer research and treatment 2006;97(3):341-3.
2005: Gianni Luca; Baselga José; Eiermann Wolfgang; Guillem Porta Vicente; Semiglazov Vladimir; Lluch Aña; Zambetti Milvia; Sabadell Dolores; Raab Günther; Llombart Cussac Antonio; Bozhok Alla; Martinez-Agulló Angel; Greco Marco; Byakhov Mikhail; Lopez Lopez Juan Josè; Mansutti Mauro; Valagussa Pinuccia; Bonadonna Gianni;
Feasibility and tolerability of sequential doxorubicin/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(24 Pt 1):8715-21.
2005: Demicheli Romano; Bonadonna Gianni; Valagussa Pinuccia; Retsky Michael W; Hrushesky William J M; Baum Michael
Comment to Jatoi et al. report.
Breast cancer research and treatment 2005;93(1):1-2.
2005: Demicheli R; Miceli R; Moliterni A; Zambetti M; Hrushesky W J M; Retsky M W; Valagussa P; Bonadonna G
Breast cancer recurrence dynamics following adjuvant CMF is consistent with tumor dormancy and mastectomy-driven acceleration of the metastatic process.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(9):1449-57.
2005: Bonadonna Gianni; Viviani Simonetta; Bonfante Valeria; Gianni Alessandro M; Valagussa Pinuccia
Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
European journal of cancer (Oxford, England : 1990) 2005;41(7):998-1006.
2005: Bonadonna Gianni; Moliterni Angela; Zambetti Milvia; Daidone Maria Grazia; Pilotti Silvana; Gianni Luca; Valagussa Pinuccia
30 years' follow up of randomised studies of adjuvant CMF in operable breast cancer: cohort study.
BMJ (Clinical research ed.) 2005;330(7485):217.
2004: Visco Carlo; Vassilakopoulos Theodoros P; Kliche Kay Oliver; Nadali Gianpaolo; Viviani Simonetta; Bonfante Valeria; Medeiros L Jeffrey; Notti P; Rassidakis George Z; Peethambaram Prema; Wilder Richard; Witzig Thomas; Gianni Massimo; Bonadonna Gianni; Pizzolo Giovanni; Pangalis Gerassimos A; Cabanillas Fernando; Sarris Andreas H
Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy.
Leukemia & lymphoma 2004;45(10):2085-92.
2004: Bonadonna Gianni; Bonfante Valeria; Viviani Simonetta; Di Russo Anna; Villani Fabrizio; Valagussa Pinuccia
ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(14):2835-41.
2004: Bonadonna Gianni; Zambetti Milvia; Moliterni Angela; Gianni Luca; Valagussa Pinuccia
Clinical relevance of different sequencing of doxorubicin and cyclophosphamide, methotrexate, and Fluorouracil in operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(9):1614-20.
2004: Demicheli Romano; Bonadonna Gianni; Hrushesky William J M; Retsky Michael W; Valagussa Pinuccia
Menopausal status dependence of early mortality reduction due to diagnosis of smaller breast cancers (T1 v T2-T3): relevance to screening.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):102-7.
2004: Demicheli Romano; Bonadonna Gianni; Hrushesky William J M; Retsky Michael W; Valagussa Pinuccia
Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour.
Breast cancer research : BCR 2004;6(6):R689-96.
2004: Retsky Michael; Bonadonna Gianni; Demicheli Romano; Folkman Judah; Hrushesky William; Valagussa Pinuccia
Hypothesis: Induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients.
Breast cancer research : BCR 2004;6(4):R372-4.
2003: Herling Marco; Rassidakis George Z; Medeiros L Jeffrey; Vassilakopoulos Theodoros P; Kliche Kay-Oliver; Nadali Gianpaolo; Viviani Simonetta; Bonfante Valeria; Giardini Roberto; Chilosi Marco; Kittas Christos; Gianni Alessandro M; Bonadonna Gianni; Pizzolo Giovanni; Pangalis Gerassimos A; Cabanillas Fernando; Sarris Andreas H
Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(6):2114-20.
2003: Licitra L; Locati L D; Cavina R; Garassino I; Mattavelli F; Pizzi N; Quattrone P; Valagussa P; Gianni L; Bonadonna G; Solero C L; Cantu G
Primary chemotherapy followed by anterior craniofacial resection and radiotherapy for paranasal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(3):367-72.
2003: Moliterni Angela; Ménard Sylvie; Valagussa Pinuccia; Biganzoli Elia; Boracchi Patrizia; Balsari Andrea; Casalini Patrizia; Tomasic Gorana; Marubini Ettore; Pilotti Silvana; Bonadonna Gianni
HER2 overexpression and doxorubicin in adjuvant chemotherapy for resectable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(3):458-62.
2003: Licitra Lisa; Grandi Cesare; Guzzo Marco; Mariani Luigi; Lo Vullo Salvatore; Valvo Francesca; Quattrone Pasquale; Valagussa Pinuccia; Bonadonna Gianni; Molinari Roberto; Cantù Giulio
Primary chemotherapy in resectable oral cavity squamous cell cancer: a randomized controlled trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):327-33.
2003: Valagussa Pinuccia; Bonadonna Gianni
Breast cancer.
Cancer chemotherapy and biological response modifiers 2003;21():585-608.
2002: Rassidakis George Z; Medeiros L Jeffrey; Vassilakopoulos Theodoros P; Viviani Simonetta; Bonfante Valeria; Nadali Gianpaolo; Herling Marco; Angelopoulou Maria K; Giardini Roberto; Chilosi Marco; Kittas Christos; McDonnell Timothy J; Bonadonna Gianni; Gianni Alessandro M; Pizzolo Giovanni; Pangalis Gerassimos A; Cabanillas Fernando; Sarris Andreas H
BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens.
Blood 2002;100(12):3935-41.
2002: Demicheli R; Valagussa P; Bonadonna G
Double-peaked time distribution of mortality for breast cancer patients undergoing mastectomy.
Breast cancer research and treatment 2002;75(2):127-34.
2002: Bonadonna G; Zambetti M; Bumma C; Donadio M; Bolognesi A; Robustelli Della Cuna G; Ambrosini G; Lelli G; Mansutti M; Verderio P; Valagussa P
Multimodal treatment with primary single-agent epirubicin in operable breast cancer: 5-year experience of the Michelangelo Cooperative Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(7):1049-58.
2002: Rassidakis George Z; Medeiros L Jeffrey; Viviani Simonetta; Bonfante Valeria; Nadali Gian-Paolo; Vassilakopoulos Theodoros P; Mesina Ofelia; Herling Marco; Angelopoulou Maria K; Giardini Roberto; Chilosi Marco; Kittas Christos; McLaughlin Peter; Rodriguez M Alma; Romaguera Jorge; Bonadonna Gianni; Gianni Alessandro M; Pizzolo Giovanni; Pangalis Gerassimos A; Cabanillas Fernando; Sarris Andreas H
CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin's disease: associations with presenting features and clinical outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1278-87.
2002: Rassidakis George Z; Medeiros L Jeffrey; McDonnell Timothy J; Viviani Simonetta; Bonfante Valeria; Nadali Gianpaolo; Vassilakopoulos Theodoros P; Giardini Roberto; Chilosi Marco; Kittas Christos; Gianni Alessandro M; Bonadonna Gianni; Pizzolo Giovanni; Pangalis Gerassimos A; Cabanillas Fernando; Sarris Andreas H
BAX expression in Hodgkin and Reed-Sternberg cells of Hodgkin's disease: correlation with clinical outcome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(2):488-93.
2002: Bidoli Paolo; Bajetta Emilio; Stani Simonetta C; De Candis Daniela; Santoro Armando; Valente Maurizio; Zucali Roberto; Valagussa Pinuccia; Ravasi Gianni; Bonadonna Gianni
Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus.
Cancer 2002;94(2):352-61.
2001: Mariani G; Tagliabue P; Zucchinelli P; Brambilla C; Demicheli R; Villa E; Marchianò A; Valagussa P; Bonadonna G; Gianni L
Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer.
Breast cancer research and treatment 2001;70(3):163-9.
2001: Demicheli R; Valagussa P; Bonadonna G
Does surgery modify growth kinetics of breast cancer micrometastases?
British journal of cancer 2001;85(4):490-2.
2001: Bonfante V; Viviani S; Devizzi L; Di Russo A; Di Nicola M; Magni M; Matteucci P; Grisanti S; Valagussa P; Bonadonna G; Gianni A M
High-dose ifosfamide and vinorelbine as salvage therapy for relapsed or refractory Hodgkin's disease.
European journal of haematology. Supplementum 2001;64():51-5.
2001: Gianni L; Valagussa P; Zambetti M; Moliterni A; Capri G; Bonadonna G
Adjuvant and neoadjuvant treatment of breast cancer.
Seminars in oncology 2001;28(1):13-29.
2001: Ménard S; Valagussa P; Pilotti S; Gianni L; Biganzoli E; Boracchi P; Tomasic G; Casalini P; Marubini E; Colnaghi M I; Cascinelli N; Bonadonna G
Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(2):329-35.
2001: Zambetti M; Moliterni A; Materazzo C; Stefanelli M; Cipriani S; Valagussa P; Bonadonna G; Gianni L
Long-term cardiac sequelae in operable breast cancer patients given adjuvant chemotherapy with or without doxorubicin and breast irradiation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(1):37-43.
2001: Valagussa P; Bonadonna G
Breast cancer.
Cancer chemotherapy and biological response modifiers 2001;19():597-628.
2000: Magni M; Di Nicola M; Devizzi L; Matteucci P; Lombardi F; Gandola L; Ravagnani F; Giardini R; Dastoli G; Tarella C; Pileri A; Bonadonna G; Gianni A M
Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion.
Blood 2000;96(3):864-9.
2000: Silvestrini R; Luisi A; Zambetti M; Cipriani S; Valagussa P; Bonadonna G; Daidone M G
Cell proliferation and outcome following doxorubicin plus CMF regimens in node-positive breast cancer.
International journal of cancer. Journal international du cancer 2000;87(3):405-11.
2000: Santoro A; Bredenfeld H; Devizzi L; Tesch H; Bonfante V; Viviani S; Fiedler F; Parra H S; Benoehr C; Pacini M; Bonadonna G; Diehl V
Gemcitabine in the treatment of refractory Hodgkin's disease: results of a multicenter phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(13):2615-9.
2000: Tondini C; Balzarotti M; Rampinelli I; Valagussa P; Luoni M; De Paoli A; Santoro A; Bonadonna G
Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: a phase II randomized study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(2):231-3.
2000: Viviani S; Notti P; Bonfante V; Verderio P; Valagussa P; Bonadonna G
Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in Hodgkin's disease, the milan cancer institute experience.
Medical oncology (Northwood, London, England) 2000;17(1):59-63.
1999: Tondini C; Ferreri A J; Siracusano L; Valagussa P; Giardini R; Rampinelli I; Bonadonna G
Diffuse large-cell lymphoma of the testis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2854-8.
1999: Viviani S; Bonfante V; Santoro A; Zanini M; Devizzi L; Di Russo A D; Soncini F; Villani F; Ragni G; Valagussa P; Bonadonna G
Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease.
The cancer journal from Scientific American 1999;5(5):275-82.
1999: Zambetti M; Oriana S; Quattrone P; Verderio P; Terenziani M; Zucali R; Valagussa P; Bonadonna G
Combined sequential approach in locally advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(3):305-10.
1999: Demicheli R; Miceli R; Brambilla C; Ferrari L; Moliterni A; Zambetti M; Valagussa P; Bonadonna G
Comparative analysis of breast cancer recurrence risk for patients receiving or not receiving adjuvant cyclophosphamide, methotrexate, fluorouracil (CMF). Data supporting the occurrence of 'cures'.
Breast cancer research and treatment 1999;53(3):209-15.
1998: Bonfante V; Viviani S; Santoro A; Devizzi L; Di Russo A; Zanini M; Soncini F; Soto Parra H; Valagussa P; Bonadonna G
Ifosfamide and vinorelbine: an active regimen for patients with relapsed or refractory Hodgkin's disease.
British journal of haematology 1998;103(2):533-5.
1998: Demicheli R; Terenziani M; Bonadonna G
Estimate of tumor growth time for breast cancer local recurrences: rapid growth after wake-up?
Breast cancer research and treatment 1998;51(2):133-7.
1998: Bonadonna G
A new philosophy in breast cancer therapy.
The cancer journal from Scientific American 1998;4(4):224-5.
1998: Viviani S; Camerini E; Bonfante V; Santoro A; Balzarotti M; Fornier M; Devizzi L; Verderio P; Valagussa P; Bonadonna G
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
British journal of cancer 1998;77(6):992-7.
1998: Bonadonna G; Valagussa P; Brambilla C; Ferrari L; Moliterni A; Terenziani M; Zambetti M
Primary chemotherapy in operable breast cancer: eight-year experience at the Milan Cancer Institute.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):93-100.
1998: Gianni L; Capri G; Valagussa P; Bonadonna G
Putting taxanes to work in operable breast cancer: a search for selective indications from empirical studies.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1998;152():314-22.
1997: Demicheli R; Retsky M W; Swartzendruber D E; Bonadonna G
Proposal for a new model of breast cancer metastatic development.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(11):1075-80.
1997: Moliterni A; Tarenzi E; Capri G; Terenziani M; Bertuzzi A; Grasselli G; Agresti R; Piotti P; Greco M; Salvadori B; Pilotti S; Lombardi F; Valagussa P; Bonadonna G; Gianni L
Pilot study of primary chemotherapy with doxorubicin plus paclitaxel in women with locally advanced or operable breast cancer.
Seminars in oncology 1997;24(5 Suppl 17):S17-10-S17-14.
1997: Retsky M W; Demicheli R; Swartzendruber D E; Bame P D; Wardwell R H; Bonadonna G; Speer J F; Valagussa P
Computer simulation of a breast cancer metastasis model.
Breast cancer research and treatment 1997;45(2):193-202.
1997: Zambetti M; Demicheli R; De Candis D; Antonelli G; Giacobone A; Terenziani M; Laffranchi A; Garbagnati F; Biasi S; Bonadonna G
Five-day infusion fluorouracil plus vinorelbine i.v. in metastatic pretreated breast cancer patients.
Breast cancer research and treatment 1997;44(3):255-60.
1997: Gianni A M; Siena S; Bregni M; Di Nicola M; Orefice S; Cusumano F; Salvadori B; Luini A; Greco M; Zucali R; Rilke F; Zambetti M; Valagussa P; Bonadonna G
Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: five-year results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2312-21.
1997: Tondini C; Balzarotti M; Santoro A; Zanini M; Fornier M; Giardini R; Di Felice G; Bozzetti F; Bonadonna G
Initial chemotherapy for primary resectable large-cell lymphoma of the stomach.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8(5):497-9.
1997: Gianni L; Viganò L; Locatelli A; Capri G; Giani A; Tarenzi E; Bonadonna G
Human pharmacokinetic characterization and in vitro study of the interaction between doxorubicin and paclitaxel in patients with breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1906-15.
1997: Gianni A M; Bregni M; Siena S; Brambilla C; Di Nicola M; Lombardi F; Gandola L; Tarella C; Pileri A; Ravagnani F; Valagussa P; Bonadonna G
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma.
The New England journal of medicine 1997;336(18):1290-7.
1997: Bonfante V; Santoro A; Viviani S; Devizzi L; Balzarotti M; Soncini F; Zanini M; Valagussa P; Bonadonna G
Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):528-34.
1997: Devizzi L; Maffioli L; Bonfante V; Viviani S; Balzarini L; Gasparini M; Valagussa P; Bombardieri E; Santoro A; Bonadonna G
Comparison of gallium scan, computed tomography, and magnetic resonance in patients with mediastinal Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1997;8 Suppl 1():53-6.
1996: Balzarotti M; Santoro A; Tondini C; Fornier M; Bonadonna G
Activity of single agent vinorelbine in pretreated non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(9):970-2.
1996: Devizzi L; Santoro A; Bonfante V; Viviani S; Bonadonna G
Vinorelbine: a new promising drug in Hodgkin's disease.
Leukemia & lymphoma 1996;22(5-6):409-14.
1996: Bonadonna G; Valagussa P
Primary chemotherapy in operable breast cancer.
Seminars in oncology 1996;23(4):464-74.
1996: Zambetti M; Valagussa P; Bonadonna G
Adjuvant cyclophosphamide, methotrexate and fluorouracil in node-negative and estrogen receptor-negative breast cancer. Updated results.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(5):481-5.
1996: Viviani S; Bonadonna G; Santoro A; Bonfante V; Zanini M; Devizzi L; Soncini F; Valagussa P
Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1421-30.
1996: Bonadonna G
Current and future trends in the multidisciplinary approach for high-risk breast cancer. The experience of the Milan Cancer Institute.
European journal of cancer (Oxford, England : 1990) 1996;32A(2):209-14.
1996: Bregni M; Siena S; Di Nicola M; Dodero A; Peccatori F; Ravagnani F; Danesini G; Laffranchi A; Bonadonna G; Gianni A M
Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):628-35.
1996: Zambetti M; Terenziani M; Bartoli C; Valagussa P; Piotti P; Ferranti C; Bonadonna G
Intermediate doses of cyclophosphamide alone or following adriamycin in advanced breast cancer. A pilot study.
American journal of clinical oncology 1996;19(1):82-6.
1996: Demicheli R; Abbattista A; Miceli R; Valagussa P; Bonadonna G
Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy.
Breast cancer research and treatment 1996;41(2):177-85.
1996: Terenziani M; Demicheli R; Brambilla C; Ferrari L; Moliterni A; Zambetti M; Caraceni A; Martini C; Bonadonna G
Vinorelbine: an active, non cross-resistant drug in advanced breast cancer. Results from a phase II study.
Breast cancer research and treatment 1996;39(3):285-91.
1996: Valagussa P; De Candis D; Antonelli G; Bonadonna G
VIII. Women's health perception and breast cancer: issues of fertility, hormone substitution, and cancer prevention.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1996;140():277-83.
1996: Bonadonna G
Future developments in adjuvant systemic therapy for high-risk breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1996;140():227-34.
1996: Santoro A; Bonadonna G
Soft tissue and bone sarcomas.
Cancer chemotherapy and biological response modifiers 1996;16():617-24.
1995: Bonadonna G; Valagussa P; Moliterni A; Zambetti M; Brambilla C
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up.
The New England journal of medicine 1995;332(14):901-6.
1995: Santoro A; Parra H S; Bidoli P; Angelidou M; Cataldo I; Salvini P; Valagussa P; Milani F; Ravasi G; Bonadonna G
A summary of the Milan experience with multimodality therapies in patients with small cell lung cancer: attempts to improve long-term outcome.
Seminars in oncology 1995;22(1 Suppl 2):9-14.
1995: Gianni L; Kearns C M; Giani A; Capri G; Viganó L; Lacatelli A; Bonadonna G; Egorin M J
Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(1):180-90.
1994: Siena S; Bregni M; Di Nicola M; Ravagani F; Peccatori F; Gandola L; Lombardi F; Tarella C; Bonadonna G; Gianni A M
Durability of hematopoiesis following autografting with peripheral blood hematopoietic progenitors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(10):935-41.
1994: Di Nicola M; Siena S; Bregni M; Ravagnani F; Vitello F; Belli N; Dodero A; Magni M; Bonadonna G; Gianni A M
Large-scale enrichment of mobilized CD34+ peripheral blood hematopoietic progenitors by removal of nylon wool-adherent mature cells.
Bone marrow transplantation 1994;14(6):863-9.
1994: Valagussa P; Moliterni A; Terenziani M; Zambetti M; Bonadonna G
Second malignancies following CMF-based adjuvant chemotherapy in resectable breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(9):803-8.
1994: Devizzi L; Santoro A; Bonfante V; Viviani S; Balzarini L; Valagussa P; Bonadonna G
Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(9):817-20.
1994: Valagussa P; Zambetti M; Biasi S; Moliterni A; Zucali R; Bonadonna G
Cardiac effects following adjuvant chemotherapy and breast irradiation in operable breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(3):209-16.
1994: Gianni A M; Tarella C; Bregni M; Siena S; Lombardi F; Gandola L; Caracciolo D; Stern A; Bonadonna G; Boccadoro M
High-dose sequential chemoradiotherapy, a widely applicable regimen, confers survival benefit to patients with high-risk multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(3):503-9.
1994: Demicheli R; Terenziani M; Valagussa P; Moliterni A; Zambetti M; Bonadonna G
Local recurrences following mastectomy: support for the concept of tumor dormancy.
Journal of the National Cancer Institute 1994;86(1):45-8.
1994: Bonadonna G
Modern treatment of malignant lymphomas: a multidisciplinary approach? The Kaplan Memorial Lecture.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 2():5-16.
1994: Santoro A; Bonadonna G
Soft tissue and bone sarcomas.
Cancer chemotherapy and biological response modifiers 1994;15():620-7.
1994: Bregni M; Siena S; Bonadonna G; Gianni A M
Clinical utilisation of human haematopoietic progenitors elicited in peripheral blood by recombinant human granulocyte colony-stimulating factor (rHuG-CSF).
European journal of cancer (Oxford, England : 1990) 1994;30A(2):235-8.
1993: Di Nicola M; Siena S; Bregni M; Peccatori F; Magni M; Ravagnani F; Zorzino L; Bonadonna G; Gianni A M
Quantization of CD34+ peripheral blood hematopoietic progenitors for autografting in cancer patients.
The International journal of artificial organs 1993;16 Suppl 5():80-2.
1993: Gianni A M; Siena S; Bregni M; Lombardi F; Gandola L; Di Nicola M; Magni M; Peccatori F; Valagussa P; Bonadonna G
High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(10):889-91.
1993: Gianni A M; Siena S; Bregni M; Di Nicola M; Peccatori F; Magni M; Ravagnani F; Sklenar I; Bonadonna G
Recombinant human interleukin-3 hastens trilineage hematopoietic recovery following high-dose (7 g/m2) cyclophosphamide cancer therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(9):759-66.
1993: Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara G P; Bonadonna G; Gianni A M
Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
Experimental hematology 1993;21(12):1583-90.
1993: Zucali R; Bidoli P; Salvini P M; Santoro A; Spinazzè S; Bonadonna G; Valente M; Alloisio M; Ravasi G
Combined radiation and chemotherapy in esophageal cancer.
Rays 1993;18(3):382-7.
1993: Bonadonna G; Gianni L; Santoro A; Bonfante V; Bidoli P; Casali P; Demicheli R; Valagussa P
Drugs ten years later: epirubicin.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(5):359-69.
1993: Tondini C; Zanini M; Lombardi F; Bengala C; Rocca A; Giardini R; Buzzoni R; Valagussa P; Bonadonna G
Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(4):720-5.
1993: Valagussa P; Moliterni A; Zambetti M; Bonadonna G
Long-term sequelae from adjuvant chemotherapy.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;127():247-55.
1993: Bonadonna G
What did we learn from the results of the international overview about the effects of endocrine therapy?
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;127():159-61.
1993: Bonadonna G; Veronesi U; Brambilla C; Ferrari L; Passoni P; Coopmans de Yoldi G F; Luini A; Greco M; Valagussa P
Primary chemotherapy for resectable breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1993;127():113-7.
1993: Santoro A; Bonadonna G
Soft tissue and bone sarcomas.
Cancer chemotherapy and biological response modifiers 1993;14():594-605.
1992: Gianni A M; Bregni M; Siena S; Magni M; Di Nicola M; Lombardi F; Tarella C; Pileri A; Bonadonna G
Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(12):1955-62.
1992: Gianni A M; Siena S; Bregni M; Bonadonna G
The use of GM-CSF and peripheral blood stem cells (PBSC) minimises haematological toxicity following a myeloablative course of chemo-radiotherapy.
Pathologie-biologie 1992;39(9):956.
1992: Bregni M; Magni M; Siena S; Di Nicola M; Bonadonna G; Gianni A M
Human peripheral blood hematopoietic progenitors are optimal targets of retroviral-mediated gene transfer.
Blood 1992;80(6):1418-22.
1992: Valagussa P; Santoro A; Bonadonna G
Thyroid, pulmonary, and cardiac sequelae after treatment for Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 4():111-5.
1992: Ferranti C; Bergonzi S; Viganotti G; Piragine G; Barberini M; Bonadonna G; Coopmans De Yoldi G
[Microcalcifications in the diagnosis and follow-up after the primary chemotherapy of breast neoplasms]
La Radiologia medica 1992;84(1-2):26-31.
1992: Casali P; Pastorino U; Zucchinelli P; Devizzi L; Azzarelli A; Quagliuolo V; Bignami P; Santoro A; Bonadonna G
Epirubicin plus ifosfamide and dacarbazine (EID) in advanced soft tissue sarcomas.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3 Suppl 2():S125-6.
1992: Bonadonna G
Evolving concepts in the systemic adjuvant treatment of breast cancer.
Cancer research 1992;52(8):2127-37.
1992: Bonfante V; Santoro A; Viviani S; Valagussa P; Bonadonna G
ABVD in the treatment of Hodgkin's disease.
Seminars in oncology 1992;19(2 Suppl 5):38-44; discussion 44-5.
1992: Bonfante V; Santoro A; Viviani S; Zucali R; Devizzi L; Zanini M; Tesoro Tess J D; Valagussa P; Banfi A; Bonadonna G
Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP.
European journal of cancer (Oxford, England : 1990) 1992;29A(1):24-9.
1991: Buzzoni R; Bonadonna G; Valagussa P; Zambetti M
Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(12):2134-40.
1991: Bonadonna G; Valagussa P; Brambilla C; Moliterni A; Zambetti M; Ferrari L
Adjuvant and neoadjuvant treatment of breast cancer with chemotherapy and/or endocrine therapy.
Seminars in oncology 1991;18(6):515-24.
1991: Gianni L; Capri G; Greco M; Villani F; Brambilla C; Luini A; Crippa F; Bonadonna G
Activity and toxicity of 4'-iodo-4'-deoxydoxorubicin in patients with advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(10):719-25.
1991: Gianni A M; Siena S; Bregni M; Lombardi F; Gandola L; Valagussa P; Bonadonna G
Prolonged disease-free survival after high-dose sequential chemo-radiotherapy and haemopoietic autologous transplantation in poor prognosis Hodgkin's disease.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(9):645-53.
1991: Moliterni A; Bonadonna G; Valagussa P; Ferrari L; Zambetti M
Cyclophosphamide, methotrexate, and fluorouracil with and without doxorubicin in the adjuvant treatment of resectable breast cancer with one to three positive axillary nodes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(7):1124-30.
1991: Siena S; Bregni M; Brando B; Belli N; Lansdorp P M; Bonadonna G; Gianni M
Flow cytometry to estimate circulating hematopoietic progenitors for autologous transplantation: comparative analysis of different CD34 monoclonal antibodies.
Haematologica 1991;76(4):330-3.
1991: Brambilla C; Escobedo A; Artioli R; Lechuga M J; Motta M; Bonadonna G
Medical castration with zoladex: a conservative approach to premenopausal breast cancer.
Tumori 1991;77(2):145-50.
1991: Viviani S; Bonadonna G; Santoro A; Zanini M; Zucali R; Negretti E; Valagussa P
Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 2():55-62.
1991: Bonadonna G; Santoro A; Gianni A M; Viviani S; Siena S; Bregni M; Zucali R; Lombardi F; Bonfante V; Gianni L
Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2 Suppl 1():9-16.
1991: Siena S; Bregni M; Brando B; Belli N; Ravagnani F; Gandola L; Stern A C; Lansdorp P M; Bonadonna G; Gianni A M
Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients.
Blood 1991;77(2):400-9.
1991: Viviani S; Ragni G; Santoro A; Perotti L; Caccamo E; Negretti E; Valagussa P; Bonadonna G
Testicular dysfunction in Hodgkin's disease before and after treatment.
European journal of cancer (Oxford, England : 1990) 1991;27(11):1389-92.
1991: Bregni M; Siena S; Magni M; Bonadonna G; Gianni A M
Circulating hemopoietic progenitors mobilized by cancer chemotherapy and by rhGM-CSF in the treatment of high-grade non-Hodgkin's lymphoma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5 Suppl 1():123-7.
1990: Bonadonna G; Veronesi U; Brambilla C; Ferrari L; Luini A; Greco M; Bartoli C; Coopmans de Yoldi G; Zucali R; Rilke F
Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more.
Journal of the National Cancer Institute 1990;82(19):1539-45.
1990: Silvestrini R; Daidone M G; Valagussa P; Di Fronzo G; Mezzanotte G; Mariani L; Bonadonna G
3H-thymidine-labeling index as a prognostic indicator in node-positive breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(8):1321-6.
1990: Gianni A M; Tarella C; Siena S; Bregni M; Boccadoro M; Lombardi F; Bengala C; Bonadonna G; Pileri A
Durable and complete hematopoietic reconstitution after autografting of rhGM-CSF exposed peripheral blood progenitor cells.
Bone marrow transplantation 1990;6(2):143-5.
1990: Bonadonna G; Valagussa P
Influence of clinical trials on current treatment strategy for Hodgkin's disease.
International journal of radiation oncology, biology, physics 1990;19(1):209-18.
1990: Zambetti M; Gianni L; Di Re F; Spatti G; Fontanelli R; Escobedo A; De Palo G; Bonadonna G
Cisplatin and cyclophosphamide in advanced ovarian carcinoma: activity and toxicity of an ambulatory regimen.
American journal of clinical oncology 1990;13(3):199-203.
1990: Valagussa P; Zambetti M; Bonadonna G; Zucali R; Mezzanotte G; Veronesi U
Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapy.
Breast cancer research and treatment 1990;15(3):137-47.
1990: Gianni A M; Bregni M; Siena S; Orazi A; Stern A C; Gandola L; Bonadonna G
Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(5):768-78.
1990: Gianni L; Viganò L; Surbone A; Ballinari D; Casali P; Tarella C; Collins J M; Bonadonna G
Pharmacology and clinical toxicity of 4'-iodo-4'-deoxydoxorubicin: an example of successful application of pharmacokinetics to dose escalation in phase I trials.
Journal of the National Cancer Institute 1990;82(6):469-77.
1990: Bonadonna G; Santoro A
Current issues in the management of advanced Hodgkin's disease.
Blood reviews 1990;4(1):69-73.
1990: Bregni M; Siena S; Ravagnani F; Bonadonna G; Gianni A M
High-dose cyclophosphamide in patients with operable breast cancer: recombinant human GM-CSF ameliorates drug-induced leukopenia and thrombocytopenia.
Haematologica 1990;75 Suppl 1():95-8.
1990: Siena S; Bregni M; Ravagnani F; Brando B; Tarella C; Bonadonna G; Gianni A M
Heterogeneity of circulating hematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF).
Haematologica 1990;75 Suppl 1():6-10.
1990: Bonadonna G
Adjuvant chemotherapy in node-negative breast cancer. NCI consensus conference.
European journal of cancer (Oxford, England : 1990) 1990;26(7):844-5.
1990: Bonadonna G
Does chemotherapy fulfill its expectations in cancer treatment?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1990;1(1):11-21.
1990: Viviani S; Santoro A; Negretti E; Bonfante V; Valagussa P; Bonadonna G
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1990;1(2):123-7.
1989: Siena S; Bregni M; Brando B; Ravagnani F; Bonadonna G; Gianni A M
Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: enhancement by intravenous recombinant human granulocyte-macrophage colony-stimulating factor.
Blood 1989;74(6):1905-14.
1989: Bonadonna G
Karnofsky memorial lecture. Conceptual and practical advances in the management of breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(10):1380-97.
1989: Gianni A M; Siena S; Bregni M; Tarella C; Stern A C; Pileri A; Bonadonna G
Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation.
Lancet 1989;2(8663):580-5.
1989: Silvestrini R; Daidone M G; Valagussa P; Di Fronzo G; Mezzanotte G; Bonadonna G
Cell kinetics as a prognostic indicator in node-negative breast cancer.
European journal of cancer & clinical oncology 1989;25(8):1165-71.
1989: Gianni A M; Bonadonna G
High dose chemo-radiotherapy for sensitive tumors: is sequential better than concurrent drug delivery?
European journal of cancer & clinical oncology 1989;25(7):1027-30.
1989: Siena S; Bregni M; Formosa A; Brando B; Marenco P; Lappi D A; Bonadonna G; Gianni A M
Immunotoxin-mediated inhibition of chronic lymphocytic leukemia cell proliferation in humans.
Cancer research 1989;49(12):3328-32.
1989: Zambetti M; Gianni L; Escobedo A; Pizzetti P; Spatti G B; Bonadonna G
First-line chemotherapy with intraperitoneal cisplatin and intravenous cyclophosphamide in ovarian carcinoma. A preliminary report.
American journal of clinical oncology 1989;12(2):118-22.
1989: Brambilla C; Zambetti M; Ferrari L; Bonadonna G
Mitomycin C and vinblastine in advanced refractory breast cancer.
Tumori 1989;75(2):141-4.
1989: Siena S; Bregni M; Formosa A; Brando B; Lappi D A; Bonadonna G; Gianni A M
Immunotoxin mediated killing of clonable T-lymphocytes infiltrating an irreversibly rejected human renal allograft.
Journal of biological regulators and homeostatic agents 1989;3(2):84-8.
1989: Bregni M; Siena S; Neri A; Bassan R; Barbui T; Delia D; Bonadonna G; Dalla Favera R; Gianni A M
Minimal residual disease in acute lymphoblastic leukemia detected by immune selection and gene rearrangement analysis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(3):338-43.
1989: Gianni A M; Bregni M; Siena S; Villa S; Sciorelli G A; Ravagnani F; Pellegris G; Bonadonna G
Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells. A changing role for high dose chemo-radiotherapy?
Hematological oncology 1989;7(2):139-48.
1989: Bidoli P; Spinazzé S; Santoro A; Bedini A V; Cataldo I; Bonadonna G
Pilot study with adriamycin and ifosfamide in small cell lung cancer.
Tumori 1989;75(1):34-7.
1989: Bregni M; Siena S; Formosa A; Lappi D A; Martineau D; Malavasi F; Dorken B; Bonadonna G; Gianni A M
B-cell restricted saporin immunotoxins: activity against B-cell lines and chronic lymphocytic leukemia cells.
Blood 1989;73(3):753-62.
1989: Valagussa P; Brambilla C; Zambetti M; Bonadonna G
Salvage treatments in relapsing resectable breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():69-76.
1989: Bonadonna G; Valagussa P; Zambetti M; Brambilla C
The Milan experience with adjuvant chemotherapy in premenopausal breast cancer.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():113-7.
1989: Bonadonna G; Zambetti M; Valagussa P
Adjuvant chemotherapy for node-negative breast cancer patients.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;115():175-9.
1989: Bonadonna G; Valagussa P; Santoro A; Viviani S; Bonfante V; Banfi A
Hodgkin's disease: the Milan Cancer Institute experience with MOPP and ABVD.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1989;117():169-74.
1988: Siena S; Bregni M; Formosa A; Martineau D; Lappi D A; Bonadonna G; Gianni A M
Evaluation of antihuman T lymphocyte saporin immunotoxins potentially useful in human transplantation.
Transplantation 1988;46(5):747-53.
1988: Verusio C; Bajetta E; Ferrari L; Bartoli C; Valagussa P; Bonadonna G
Cyclophosphamide, adriamycin, and cis-platinum (CAP) in metastatic and locally advanced breast cancer.
American journal of clinical oncology 1988;11(4):435-9.
1988: Siena S; Lappi D A; Bregni M; Formosa A; Villa S; Soria M; Bonadonna G; Gianni A M
Synthesis and characterization of an antihuman T-lymphocyte saporin immunotoxin (OKT1-SAP) with in vivo stability into nonhuman primates.
Blood 1988;72(2):756-65.
1988: Bajetta E; Valagussa P; Bonadonna G; Lattuada A; Buzzoni R; Rilke F; Banfi A
Combined modality treatment for stage I-II non-Hodgkin's lymphomas: CVP versus BACOP chemotherapy.
International journal of radiation oncology, biology, physics 1988;15(1):3-12.
1988: Bregni M; Lappi D A; Siena S; Formosa A; Villa S; Soria M; Bonadonna G; Gianni A M
Activity of a monoclonal antibody-saporin-6 conjugate against B-lymphoma cells.
Journal of the National Cancer Institute 1988;80(7):511-7.
1988: Bonadonna G; Valagussa P
The contribution of medicine to the primary treatment of breast cancer.
Cancer research 1988;48(9):2314-24.
1988: Bajetta E; Buzzoni R; Valagussa P; Bonadonna G
Mitoxantrone: an active agent in refractory non-Hodgkin's lymphomas.
American journal of clinical oncology 1988;11(2):100-3.
1987: Ferrari L; Bajetta E; Gianni L; Verusio C; Bartoli C; Valagussa P; Bonadonna G
Four-drug sequential regimen in advanced breast cancer.
Breast cancer research and treatment 1987;10(2):151-7.
1987: Weiss R B; Valagussa P; Moliterni A; Zambetti M; Buzzoni R; Bonadonna G
Adjuvant chemotherapy after conservative surgery plus irradiation versus modified radical mastectomy. Analysis of drug dosing and toxicity.
The American journal of medicine 1987;83(3):455-63.
1987: Zambetti M; Brambilla C; Tancini G; Bonadonna G
Aminoglutethimide in postmenopausal breast cancer refractory to multiple hormonal and cytostatic treatments.
Tumori 1987;73(4):369-73.
1987: Siena S; Villa S; Bonadonna G; Bregni M; Gianni A M
Ex vivo depletion of human bone marrow T lymphocytes by soybean lectin fractionation followed by treatment with an anti-pan-T cell (CD5) ricin A- chain immunotoxin.
Transplantation proceedings 1987;19(1 Pt 3):2735-7.
1986: Valagussa P; Santoro A; Fossati-Bellani F; Banfi A; Bonadonna G
Second acute leukemia and other malignancies following treatment for Hodgkin's disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(6):830-7.
1984: Bonadonna G; Bignami P; Buzzoni R; Moliterni A; Valagussa P; Veronesi U
New adjuvant trials for resectable breast cancer at the Istituto Nazionale Tumori of Milan.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1984;91():210-3.
1983: Bajetta E; Buzzoni R; Rilke F; Valagussa P; Rovej R; Viviani S; Lattuada A; Banfi A; Bonadonna G
Non-Hodgkin's lymphomas of Waldeyer's ring.
Tumori 1983;69(2):129-36.
1982: Valagussa P; Santoro A; Fossati Bellani F; Franchi F; Banfi A; Bonadonna G
Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease.
Blood 1982;59(3):488-94.
1981: Bonadonna G; Rossi A; Tancini G; Bajetta E; Marchini S; Brambilla C; Tesoro Tess J D; Valagussa P; Banfi A; Veronesi U
Adjuvant combination chemotherapy for operable breast cancer. Trials in progress at the Istituto Nazionale Tumori of Milan.
Cancer treatment reports 1981;65 Suppl 1():61-5.
1980: Monfardini S; Banfi A; Bonadonna G; Rilke F; Milani F; Valagussa P; Lattuada A
Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma.
International journal of radiation oncology, biology, physics 1980;6(2):125-34.
1980: Valagussa P; Santoro A; Kenda R; Fossati Bellani F; Franchi F; Banfi A; Rilke F; Bonadonna G
Second malignancies in Hodgkin's disease: a complication of certain forms of treatment.
British medical journal 1980;280(6209):216-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Gianni Bonadonna

Research Profile (preview)

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Gianni Bonadonna (preview)

All Publications